Page last updated: 2024-08-25

corilagin and Bone Loss, Osteoclastic

corilagin has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Y; He, R; Hou, W; Huang, D; Huang, Y; Kuang, Z; Lu, J; Tang, L; Xiao, S; Ye, C; Yishake, M1

Other Studies

1 other study(ies) available for corilagin and Bone Loss, Osteoclastic

ArticleYear
Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-κB and PI3K/AKT signalling pathways.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:18

    Topics: Actins; Animals; Bone Marrow Cells; Bone Resorption; Down-Regulation; Estrogens; Glucosides; Hydrolyzable Tannins; Mice; Mice, Inbred C57BL; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoprotegerin; Ovariectomy; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RANK Ligand; RAW 264.7 Cells; Reactive Oxygen Species; RNA, Messenger; Signal Transduction

2020